Literature DB >> 12729334

Olaf Scheel and Johannes Heimbeck: their contribution to understanding the pathogenesis and prevention of tuberculosis.

K Bjartveit1.   

Abstract

From 1924 onwards, mandatory tuberculin testing (von Pirquet's method) was introduced for student nurses on entry to the Ullevaal Hospital School of Nursing, Oslo. The chief physician of the hospital's Department IX, Olaf Scheel, was responsible for this measure. In 1927, his deputy Johannes Heimbeck showed that about half of the students were not infected at the time of entry, a conclusion that was in fundamental conflict with the prevailing view that nearly all tuberculous infection occurred in childhood. Virtually all tuberculin-negative student nurses, however, became infected during their 3-year training. These findings changed our understanding of the pathogenesis of tuberculosis. BCG vaccination had recently been introduced by Calmette. From 1927 onwards Heimbeck offered BCG vaccination to tuberculin-negative student nurses, while Scheel undertook a similar project among medical students. The two projects continued until respectively 1936 and 1939. Long-term follow-up of both groups demonstrated a protective effect of about 80% in those accepting vaccination. Calmette had given the vaccine per os to new-born babies. Heimbeck and Scheel pioneered giving the vaccine via injection and to adults. These projects have been criticised for being based on voluntary inclusion and not being conducted as randomised control trials. The results were so convincing, however, that they led to the launch of the Norwegian BCG programme shortly after World War II. Scheel and Heimbeck' efforts were also of great importance for the use of the BCG vaccine in other countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729334

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  Tuberculosis in a South African prison - a transmission modelling analysis.

Authors:  Simon Johnstone-Robertson; Stephen D Lawn; Alex Welte; Linda-Gail Bekker; Robin Wood
Journal:  S Afr Med J       Date:  2011-11-01

Review 2.  Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.

Authors:  Jason R Andrews; Farzad Noubary; Rochelle P Walensky; Rodrigo Cerda; Elena Losina; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

3.  Tuberculosis and Healthcare Workers in Underresourced Settings.

Authors:  Thomas G Evans; Linda-Gail Bekker
Journal:  Clin Infect Dis       Date:  2016-05-15       Impact factor: 9.079

Review 4.  Tuberculosis vaccines and prevention of infection.

Authors:  Thomas R Hawn; Tracey A Day; Thomas J Scriba; Mark Hatherill; Willem A Hanekom; Thomas G Evans; Gavin J Churchyard; James G Kublin; Linda-Gail Bekker; Steven G Self
Journal:  Microbiol Mol Biol Rev       Date:  2014-12       Impact factor: 11.056

5.  A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.

Authors:  Carolyn M Shoen; Michelle S DeStefano; Cynthia C Hager; Kyi-Toe Tham; Miriam Braunstein; Alexandria D Allen; Hiriam O Gates; Michael H Cynamon; Douglas S Kernodle
Journal:  Vaccines (Basel)       Date:  2013-01-11

6.  High risk for latent tuberculosis infection among medical residents and nursing students in India.

Authors:  Aarti Kinikar; Ajay Chandanwale; Dileep Kadam; Samir Joshi; Anita Basavaraj; Geeta Pardeshi; Sunita Girish; Sangeeta Shelke; Andrea DeLuca; Gauri Dhumal; Jonathan Golub; Nilima Lokhande; Nikhil Gupte; Amita Gupta; Robert Bollinger; Vidya Mave
Journal:  PLoS One       Date:  2019-07-08       Impact factor: 3.752

7.  BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers.

Authors:  Mark Hatherill; Thomas J Scriba; Zarir F Udwadia; Jai B Mullerpattan; Anthony Hawkridge; Hassan Mahomed; Christopher Dye
Journal:  Clin Infect Dis       Date:  2016-05-15       Impact factor: 9.079

8.  Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

Authors:  Shanmugalakshmi Sadagopal; Miriam Braunstein; Cynthia C Hager; Jie Wei; Alexandria K Daniel; Markian R Bochan; Ian Crozier; Nathaniel E Smith; Hiriam O Gates; Louise Barnett; Luc Van Kaer; James O Price; Timothy S Blackwell; Spyros A Kalams; Douglas S Kernodle
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

9.  Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49.

Authors:  Knut Liestøl; Steinar Tretli; Aage Tverdal; Jan Maehlen
Journal:  Int J Epidemiol       Date:  2009-04       Impact factor: 7.196

10.  Increase of CD4+CD25highFoxP3+ cells impairs in vitro human microbicidal activity against Mycobacterium tuberculosis during latent and acute pulmonary tuberculosis.

Authors:  Lorenzzo Lyrio Stringari; Luciana Polaco Covre; Flávia Dias Coelho da Silva; Vivian Leite de Oliveira; Maria Carolina Campana; David Jamil Hadad; Moisés Palaci; Padmini Salgame; Reynaldo Dietze; Daniel Cláudio de Oliveira Gomes; Rodrigo Ribeiro-Rodrigues
Journal:  PLoS Negl Trop Dis       Date:  2021-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.